Which of the following is not a cyclin dependent kinase (CDK) inhibitor?
**Core Concept**
Cyclin-dependent kinases (CDKs) are crucial regulators of the cell cycle, particularly during the transition from one phase to the next. CDK inhibitors, on the other hand, are a class of molecules that regulate CDK activity, thereby controlling cell cycle progression.
**Why the Correct Answer is Right**
The correct answer is a cyclin-dependent kinase (CDK) inhibitor, which means it regulates CDK activity to control cell cycle progression. CDK inhibitors specifically target the CDK-cyclin complex, preventing its activation. This is essential for maintaining cell cycle checkpoints and preventing uncontrolled cell growth. For example, p21 (a CDK inhibitor) binds to CDK2 and prevents its interaction with cyclin E, thereby inhibiting the G1-S phase transition.
**Why Each Wrong Option is Incorrect**
* **Option A:** This is indeed a CDK inhibitor, known for its role in regulating the G1-S phase transition by inhibiting CDK2 and CDK4.
* **Option B:** This is another CDK inhibitor that specifically targets CDK1 and CDK2, preventing their activation and inhibiting cell cycle progression.
* **Option D:** This is a CDK inhibitor that regulates the G2-M phase transition by inhibiting CDK1.
**Clinical Pearl / High-Yield Fact**
CDK inhibitors have emerged as a promising class of anticancer agents, particularly in treating various types of cancer, including breast, lung, and melanoma. They work by selectively targeting CDKs, thereby inhibiting cell cycle progression and inducing apoptosis in cancer cells.
**Correct Answer:** D. **Pemetrexed is an antifolate chemotherapeutic agent, not a CDK inhibitor.**